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Abstract:  21 
Chronic pulmonary infection with Pseudomonas aeruginosa is a feature of cystic 22 
fibrosis (CF) and other chronic lung diseases. Cytokines of the IL-17 family have 23 
been proposed as important in the host response to P. aeruginosa infection through 24 
augmenting antibacterial immune responses, although their pro-inflammatory effect 25 
may contribute to lung damage that occurs as a result of chronic infection. We set out 26 
to explore the role of IL-17 in the host response to chronic P. aeruginosa infection. 27 
We used a murine model of chronic pulmonary infection with CF-related strains of P. 28 
aeruginosa. We demonstrate that IL-17 cytokine signaling is essential for survival 29 
and prevention of chronic infection at 2 weeks post-inoculation using two different P. 30 
aeruginosa strains. Following infection, there was a marked expansion of cells within 31 
mediastinal lymph nodes, comprised mainly of innate lymphoid cells (ILCs); ~90% of 32 
IL-17 producing cells had markers consistent with Group 3 ILCs. A smaller 33 
percentage of IL-17+ cells had markers consistent with a B1 phenotype. In lung 34 
homogenates 14 days following infection, there was a significant expansion of IL-17+ 35 
cells – about 50% of these were CD3+, split equally between CD4+ Th17 cells and γδ 36 
T cells, while the CD3- IL-17+ cells were almost exclusively Group 3 ILCs. Further 37 
experiments with B cell deficient mice showed that B cell production of IL-17 or 38 
natural antibodies did not provide any defence against chronic P. aeruginosa 39 
infection. Thus, IL-17 rather than antibody is a key element in host defence against 40 
chronic pulmonary infection with P. aeruginosa. 41 
  42 
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Introduction 43 
Some bacteria have evolved the ability to produce chronic infection of the 44 
respiratory tract. Mycobacterium tuberculosis is perhaps the best known example, but 45 
the Gram negative pathogen Pseudomonas aeruginosa (PA) can also become 46 
persistent in the lower airways, notably in patients with Cystic Fibrosis (CF) and 47 
bronchiectasis, but also increasingly recognized in other chronic lung disease such as 48 
Chronic Obstructive Pulmonary Disease (COPD). In CF, PA infections are initially 49 
intermittent and can be eradicated by intensive antibiotic treatment(1). Transition to 50 
chronic PA airways infection usually ensues, such that by age 20, 60 – 70% of CF 51 
patients are chronically infected(2). The continuous presence of PA in the airways is 52 
accompanied by inexorable decline in respiratory function leading to premature death 53 
or lung transplantation(3). Thus, this switch from intermittent to chronic infection is a 54 
key event in the progression of disease(1). Although antibiotics can delay this 55 
transition, better therapies aimed at preventing chronic infection could potentially 56 
significantly attenuate the rate of decline in lung function in patients affected by CF, 57 
as well in other chronic lung diseases in which chronic PA infection occurs.. 58 
 Little is known of the mechanisms of host defence against chronic PA 59 
infection. Cytokines of the IL-17 family have been suggested as important in 60 
protection against PA infection. IL-17 in the lung may be important in host defense 61 
against PA through its ability to orchestrate a neutrophil response, as well as 62 
induction of a variety of innate antimicrobial peptides(4). Increased levels of IL-17A 63 
(hereafter referred to as IL-17) are found in sputum and bronchial lavage specimens 64 
of patients with CF(5), produced by a variety of cells of the innate and acquired 65 
immune system, including T cells of the Th17 lineage(6-9). Other cells known to 66 
produce IL-17 include, inter alia, innate lymphoid cells, γδ T cells and NK cells. 67 
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Although such inflammatory responses can contribute to host defence they also can 68 
potentially cause tissue damage, as is well known for M. tuberculosis infection, where 69 
the host inflammatory response can result in significant tissue damage. Pro-70 
inflammatory actions of IL-17 in PA infection could increase tissue damage through 71 
excess neutrophil accumulation and induction of matrix metalloproteinases(10). 72 
Indeed, the inflammatory changes and subsequent bronchiectasis so typical of CF 73 
have been suggested to be driven by IL-17 cytokines. Although one study examined 74 
the role of IL-17 in acute infection(11), the specific role of IL-17 in chronic PA 75 
infection has not been addressed.  76 
Herein, we have defined the interactions and effector functions of the IL-17 77 
axis in the pathogenesis of chronic pulmonary PA infection. Using a murine model, 78 
we show that IL-17 signaling is crucial in host defence against chronic PA infection, 79 
protecting against chronic colonization and death. Despite increased bacterial burden, 80 
mice lacking IL17 signaling had less weight loss compared to controls. We identified 81 
a diverse range of cellular sources of IL-17 in both draining mediastinal lymph nodes 82 
and in lung following infection.   83 
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Materials and Methods 84 
Agar Bead Infection Model 85 
The infection model was adapted from the protocol described by van Heeckeren et 86 
al.(12) and modified as described(13). Pseudomonas aeruginosa-laden agar beads 87 
were prepared the day before inoculation, stored overnight at 4oC, and a different 88 
bead preparation used for each experiment. PA-laden beads were stored on ice 89 
throughout the murine surgery. Following inoculation of PA-laden beads, the 90 
administrated inoculum was confirmed by homogenization and quantitative 91 
bacteriology on a further two aliquots of beads. Sterile agar beads were stored at 4oC 92 
and used for several experiments. Sterile agar bead preparations were confirmed to be 93 
sterile before and after each use. For knockout experiments, all animals (knockout and 94 
WT controls) were treated with PA-laden beads. In separate experiments, WT mice 95 
were treated with either PA-laden or sterile agar beads. 96 
For inoculation of PA-laden beads, mice were anaesthetized using isofluorane 97 
via nose cone and the trachea exposed and cannulated (22G intravenous cannulae; BD 98 
Biosciences) under aseptic conditions. An average inoculum of 1x106CFU/50ul per 99 
mouse was delivered. Animals were monitored closely post-operatively using a 100 
disease severity scoring system (Supplementary Table S1). An animal reaching a 101 
moribund end-point was euthanized.  102 
In surviving animals at 14 days after infection, animals were culled and in 103 
some, lungs were removed, mechanically homogenized and aliquots plated on 104 
bacteriological media to identify numbers of colony forming units of P. aeruginosa. 105 
Chronicity rates were defined as the percentage of animals at 14 days after infection 106 
that had viable P. aeruginosa recovered from lung using this method. 107 
 108 
 o
n
 O
ctober 20, 2016 by SW
ETS SUBSCRIPTIO
N SERVICE
http://iai.asm
.org/
D
ow
nloaded from
 
 6
Flow cytometry 109 
The following antibodies were used for flow cytometry: CD3e (145-2C11, 110 
eBioscience and BioLegend), CD19 (eBio1D3, eBioscience and 6D5, BioLegend); 111 
CD4 (GK1.5), CD5 (53-7.3), CD11c (N418), CD23 (B3B4), CD43 (eBioR2/60), γδ-112 
TCR (UC7-13D5), IFN-γ (XMG1.2), IgD (11-26c), IgM (II/41) (all eBioscience); 113 
CD45R/B220 (RA3-6B2), GM-CSF (MP1-22E9), Gr-1 (RB6-8C5), IL-17A (TC11-114 
18H10.1) (all BioLegend); IL-22 (3F11, Genentech). Isotype controls were used to 115 
confirm specificity of staining. For intracellular staining, cells were polyclonally 116 
stimulated with 50ng/ml PMA and 500ng/ml ionomycin in the presence of Brefeldin 117 
A (BD GolgiPlug at 1μg/ml) at 37oC for 5 hours, fixed using 4% paraformaldehyde 118 
(Thermo Scientific) in PBS for 10 minutes at 4oC and then washed in FACS buffer 119 
(PBS, 2% FCS, 0.09% sodium azide (Sigma-Aldrich)). Cells were permeabilized 120 
using PermWash buffer (BD Biosciences) prior to staining. Dead cells were detected 121 
by eFluor506 (eBioscience). For neutrophil quantification via flow cytometry, 122 
CountBright Absolute Counting Beads (Invitrogen) were added prior to washing cells 123 
and used according to the manufacturer’s instructions. Stained cells were analyzed 124 
using FACs Aria (BD Biosciences) and FlowJo software (Treestar). 125 
P. aeruginosa strains 126 
The clinical NH57388A strain was provided by N. Hoffmann (University of 127 
Copenhagen), the strain possesses a mutation in mucA resulting in alginate hyper-128 
production(14). The mucoid YH5 strain and non-mucoid GRI-1 strains were obtained 129 
locally, from a patient with CF and with ventilator-associated pneumonia, 130 
respectively. PA strains were maintained in -80oC stocks until required. Prior to use in 131 
cell culture, each strain was grown to mid-log phase in Luria-Bertani (LB) broth 132 
(Invitrogen) and the bacterial concentration at OD600 readings between 0.4 and 0.6 133 
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was quantified by serial dilution and plating to enumerate colony-forming units 134 
(CFU) (GeneQuant Pro spectrophotometer, Amersham Biosciences). Heat-killed PA 135 
preparations were produced by heating a known concentration of PA in PBS to 95oC 136 
for 10 min. 137 
Cytokine measurement 138 
Murine IL-17A, IL-17F, IL-21, IL-22, and IFN-γ were quantified by ELISA (all 139 
eBioscience). Lower limits of detection were: IL-17A < 4pg/ml, IL-17F < 15pg/ml, 140 
IL-21 < 16pg/ml, IL-22 < 8pg/mL, and IFN-γ < 15 pg/ml. Cytokine levels less than 141 
the lower limits of detection of the assay were assigned a value of zero. 142 
Immunochemistry and Histology scoring  143 
Lung sections were stained with Brilliant Violet 421 anti-B220 (Clone: RA3-6B2; 144 
Biolegend) and anti-CD90.2 (Thy1.2) (Clone: 53-2.1; Biolegend) conjugated with 145 
AlexFluor 488 streptavidin (both at concentration 1:50). SYTOX Green nuclear stain 146 
(Invitrogen) was used at a concentration of 1:10,000. The histology scoring system 147 
used is shown in Supplementary Table S2. 148 
Animals 149 
All mice were used between 12 and 16 weeks of age. IL-17RA KO mice(15) were 150 
from T. Mitchell, University of Glasgow and originally supplied by Jay Kolls; µMT 151 
mice(16) were from R. Nibbs, University of Glasgow. All these lines were on a 152 
C57BL/6 background. C57BL/6 mice bred in-house were used as wild-type controls 153 
for knockout comparisons. Animal work was carried out under a Project Licence as 154 
required by UK Home Office regulations as well as scrutiny and approval by an 155 
Institutional Review board. 156 
Ethics 157 
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The animal studies were approved by the granting of a project licence from the UK 158 
Home Office, a ministerial government department that oversees all experimental 159 
work with animals in the UK. The project licence number is 60/4361. This work was 160 
also reviewed and approved by the University of Glasgow Animal Welfare and 161 
Ethical Review Board, under the same licence number. 162 
Mediastinal lymph node, splenocyte and peritoneal B1a cell stimulation.  163 
Mediastinal lymph nodes and spleens were passed through 80μm nitex mesh and 164 
RBCs lysed (RBC lysis buffer; Sigma-Aldrich) to form a single cell suspension. Cells 165 
were either left unstimulated or stimulated with heat-killed PA at MOI30. Following 3 166 
days of culture, 100μl supernatant was removed for cytokine and PA-specific 167 
antibody quantification and cells prepared for flow cytometry.  168 
Lung homogenates, Bronchoalveolar lavage (BAL) and pleural washes  169 
Lung tissue was agitated for 1 h at 37oC with 10 μg/ml DNase (Roche) and 170 
0.65units/ml liberase (Roche), prior to passing through 80μm nitex mesh and RBC 171 
lysis to obtain as single cell suspension. BAL and pleural wash samples underwent 172 
RBC lysis. Cells were then prepared for flow cytometry. 173 
PA-specific Immunoglobulin quantification 174 
The ELISA-based method of detecting PA-specific IgM and IgG was adapted from 175 
Moser et al(17). Bound antibody was quantified by detection of biotinylated goat anti- 176 
mouse IgM (mu chain specific; VectorLabs) or anti-mouse IgG (Fc specific; Sigma-177 
Aldrich). 178 
Sequence Analysis 179 
Genomes were compared using progressive Mauve. 180 
Statistics 181 
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Results are presented as medians or, for technical repeats, mean and standard error of 182 
the mean (SEM). Non-parametric statistical tests were used (Mann-Whitney, Kruskal-183 
Wallis (KW), and, where appropriate, Dunn’s multiple comparison test). For 184 
parametric testing, Student’s 2-sample t-test was used. Comparison of animal weight 185 
changes were analysed using a repeated-measures ANOVA. Statistical analysis was 186 
undertaken using Prism Version 6.0 (GraphPad Software). A p-value of <0.05 was 187 
considered significant. 188 
  189 
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Results 190 
Establishment of a model of chronic pulmonary infection with PA 191 
 We adapted the well-established agar bead model of PA infection in mice(18, 192 
19). We used two different clinical strains of PA: YH5, a mucoid isolate from a 193 
patient with CF and NH57388A(14) a highly mucoid strain of PA from a patient with 194 
CF that carries a mutation in the mucA gene, resulting in alginate overproduction, a 195 
common phenotypic change in PA isolates following chronic infection of the airways 196 
in CF patients(20). We performed draft whole genomic sequencing of the YH5 strain 197 
and compared it with the published sequences of the type strain PAO1(21) and 198 
NH57388A(22). Comparison of the whole genomes (Supplementary Fig. S1A) shows 199 
the typical pattern of strain differences in this species, with blocks of highly 200 
conserved sequences interspersed with regions of insertions or deletions; note a 201 
segment of the NH57388 genome is inverted relative to PAO1. Of the many 202 
differences of note is the disruption of the mucA gene in NH57388 (Supplementary 203 
Fig. S1B), encoding an anti-sigma factor that is responsible for the mucoid phenotype 204 
of this strain(14). This gene is retained in PAO1 and YH5. Another significant 205 
difference is the loss of some of the genes of the phenazine biosynthesis pathway in 206 
YH5 (Supplementary Fig S1C). This pathway is essential for the synthesis of 207 
pyocyanin, an important virulence factor for P. aeruginosa(23). These differences are 208 
considered further in the Discussion. 209 
Following trans-tracheal delivery of PA-laden beads, virtually all animals 210 
recovered completely following anaesthesia (4 fatalities within 1 hour in 300 211 
procedures). YH5 infected animals remained well for the 14 day period of each 212 
experiment, with no differences in clinical score between animals delivered PA-laden 213 
beads compared to those given sterile beads. However, weight loss following bead 214 
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delivery was significantly greater in mice given the YH5 PA-laden beads compared to 215 
those receiving sterile beads(24). Following NH57388A inoculation, there was a 216 
variable amount of early mortality (< 4 days), between 0 and 40%. Surviving animals 217 
remained well. No animals developed bacteremia following pulmonary infection. At 2 218 
weeks following delivery of beads, NH57388A infection resulted in mean chronicity 219 
rates of 43.4% (SD 23.9%; range 11.1-71.5%; results from 5 experiments with 7-10 220 
surviving animals/group). The YH5 strain resulted in mean chronicity rates of 18.82% 221 
(SD 20.54%; range 0-37.5%; results from 6 experiments with 7-14 surviving 222 
animals/group) at 14 days post-inoculum.  223 
As a measure of the inflammatory response following infection, we 224 
enumerated neutrophil numbers in BAL two weeks following infection ((13) and 225 
Supplementary Fig S2). These showed animals with viable bacteria within their lungs 226 
at 2 weeks following infection had significantly elevated neutrophils within BAL 227 
compared to animals receiving sterile beads or those that had cleared the infection. 228 
Bacterial colony counts in chronically infected animals at 2 weeks after 229 
infection were very similar between the two organisms (Supplementary Fig S3A); 230 
lung homogenates from animals receiving sterile beads contained no organisms. A 231 
notable feature of NH57388A PA colonies recovered from the lungs of chronically 232 
infected animals was the appearance of many small colony variants (Supplementary 233 
Fig S3B), a common phenotypic variant found in clinical PA isolates, associated with 234 
greater biofilm formation and antibiotic resistance. These small colony variants were 235 
present in over 80% of chronically infected animals and could be seen as early as 4 236 
days after infection. Small colony variants were not seen following infection with the 237 
YH5 strain. 238 
 o
n
 O
ctober 20, 2016 by SW
ETS SUBSCRIPTIO
N SERVICE
http://iai.asm
.org/
D
ow
nloaded from
 
 12
Use of the GR-1 strain, recovered from a patient with ventilator-associated 239 
pneumonia, resulted in death with 24 hours of infected animals with a marked 240 
hemorrhagic pneumonia, and was thus not used further in our animal models of 241 
chronic infection. 242 
IL-17RA dependent signaling mediates resistance to chronic infection with PA 243 
We compared the response to PA infection between wild-type (WT) animals, 244 
and mice lacking the IL-17RA receptor chain that mediates IL-17 family actions(25). 245 
Following inoculation with the YH5 PA strain, infection rates 2 weeks later increased 246 
from 25% in WT animals (5 out of 20 animals) to 100% in IL-17RA knockout mice 247 
(20 out of 20 animals) a highly significant difference (p < 0.0001, Fisher’s Exact test). 248 
Pulmonary bacterial load was significantly increased in the IL-17RA knockout 249 
animals at 2 weeks following infection (Fig 1A), but none of the infected animals died 250 
or became bacteremic. In striking contrast to the YH5 strain, infection of IL-17RA 251 
animals with the NH57388A PA strain resulted in death of all infected animals within 252 
3 days of infection (Fig 1B) a statistically significant difference from WT littermates. 253 
All YH5 infected animals showed an initial drop in weight, as well as the 254 
subgroup of those that became chronically colonized (Fig 1C). However, IL-17RA 255 
knockout mice showed a smaller initial weight loss and early recovery of their starting 256 
weight after infection, a significant difference from the WT animals (Fig 1C).  257 
Leukocyte, Cytokine and Histological Responses Following Infection 258 
 In wild-type animals, IL-17A and IL-22 were found in low levels in BAL both 259 
at 48 h (Supplementary Fig. S3C and D) and 2 weeks (Supplementary Fig. S3E and F) 260 
following infection, but there was no significant difference between infected animals 261 
and sterile bead treated controls. Surprisingly, comparison of IL-17RA knockout and 262 
WT mice demonstrated that 2 weeks following infection with the YH5 strain, there 263 
 o
n
 O
ctober 20, 2016 by SW
ETS SUBSCRIPTIO
N SERVICE
http://iai.asm
.org/
D
ow
nloaded from
 
 13
was no significant difference in absolute neutrophil counts in the BAL 264 
(Supplementary Fig. S3G); similar results were found following infection with the 265 
NH57388A strain (data not shown).  266 
 Two weeks after infection, animals showed persistent inflammatory changes 267 
in the lung, with localized peribronchial mononuclear infiltrates, with an agar bead 268 
frequently evident in the adjacent airway (Fig 1D-E). There was no significant 269 
difference in overall histological score between WT and IL-17RA knockouts (Fig 270 
1G). However, we did observe areas of very extensive (> 50 cells deep) monocytic 271 
infiltrates in response to chronic PA infection in IL-17RA (Fig 1F) knockout animals 272 
that were never seen in the WT mice.  273 
IL-17A Production in PA Specific Immune Responses Following Infection 274 
 Two weeks following PA infection, there was a marked enlargement of the 275 
mediastinal lymph nodes compared to control animals (3.56 x 106 cells mean value for 276 
NH57388A infected animals versus 2.83 x 105 cells mean value for sterile bead 277 
treated animals; three separate experiments, p < 0.05, t-test). Ex-vivo restimulation of 278 
these lymph node cells from infected animals with heat-killed bacteria of the infecting 279 
strain NH73788A or an unrelated clinical PA strain GRI-1 for 3 days resulted in 280 
robust production of IL-17A, which was not evident in animals receiving sterile beads 281 
(Fig 2A). To characterize the cells producing these cytokines, we stained them for a 282 
variety of phenotypic surface and intracellular markers. Initially, cells from infected 283 
animals were stained for the T cell marker CD3 (Fig 2B). Comparison with cells 284 
stained with an isotype control showed two populations: a very clear CD3+ population 285 
with low side-scatter outlined in black, and a more diffuse population with lower 286 
expression of CD3 (outlined in red) that overlapped considerably with cells stained 287 
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with the isotype control. We denoted these populations as CD3 intermediate-high 288 
(CD3int-hi) and CD3 low-intermediate (CD3lo-int) respectively. 289 
Following restimulation with NH57388A, in cells from infected animals there 290 
was a marked expansion of CD3lo-int cells that was not seen in cells from animals that 291 
had received sterile beads (Fig 2B). There was also an increase in the numbers of 292 
CD3int-hi cells in the nodes of infected animals; these too increased in numbers in 293 
response to restimulation, but to a lesser extent than the CD3lo-int population (Fig 2B). 294 
There was very limited expression of IL-17A or IFN-γ within the CD3int-hi population 295 
(Fig 2C). However, in the CD3lo-int population there was a significant population of 296 
both IL-17A and IFN-γ producing cells (Fig 2D), predominantly from mediastinal 297 
lymph node cells of PA-infected animals re-challenged with the infecting PA strain ex 298 
vivo. The percentage of restimulated cells producing IL-17A that were in the CD3lo-int 299 
population was 98% of the combined (CD3lo-int + CD3int-hi) population.  300 
 We analysed the IL-17 production within this CD3lo-int population further. 301 
~90% of these cells making IL-17 were also negative for the B cell markers CD19 302 
and B220 (Fig 2E), consistent with Group 3 innate lymphoid cells (ILCs). However, 303 
reproducibly 5-10% of this CD3lo-int IL17+ population were positive for both of these 304 
B cell markers (Fig 2E). Over 90% of these CD3lo-int CD11c- ( a dendritic cell marker) 305 
B220+ CD19+ IL-17+ cells were positive for CD5 (Fig S4), consistent with a B1a 306 
population(26) Further characterization of the CD3lo-int CD19- mediastinal lymph node 307 
cells expressing IL-17 showed that very few expressed Granulocyte Macrophage 308 
colony-stimulating factor (GM-CSF). Over 60% of the CD3lo-int- CD19- cells 309 
expressed interferon-γ, but co-expression of IL-17 and interferon-γ was only seen in a 310 
minority of these cells (Fig 2E). The IL17+ CD3lo-int CD19- cells were also essentially 311 
negative for the dendritic cell marker CD11c (Fig 2E) and the Natural Killer (NK) 312 
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cell marker NK1.1 (data not shown). Taken together, these data show that the large 313 
expansion of cells within the mediastinal lymph nodes 2 weeks following infection 314 
with PA were largely composed of cells with the characteristics of ILCs; those 315 
expressing IL17 belong to the Group 3 ILC family(27-29). This is considered further 316 
in the Discussion. 317 
We analysed PA-specific immunoglobulin production from the mediastinal 318 
lymph node cells. We detected a 5- to 9- fold rise in PA reactive IgM but not IgG in 319 
the supernatants from re-stimulated lymph node cells compared to unstimulated cells 320 
(Fig 2F). This was observed both for ex vivo response of lymph node cells to the 321 
infecting NH57883A and unrelated GRI-1 strains. 322 
Importantly, we adopted a strict gating strategy to exclude ‘doublets’ which 323 
might otherwise result in inclusion of T:B cell couples, positive for both B cell 324 
markers such as B220 and CD19. This removed doublets on the basis of their 325 
increased pulse width relative to side-scatter area (Supplementary Fig. S5A – C;(30)). 326 
In addition, all analyses were performed under conditions that minimize doublet 327 
formation: cell densities less than 106cells/ml, less than maximal flow rates and after 328 
vortexing of cells(30). All analyses were performed using the double gating strategy 329 
shown in Fig S5; in practice, this made little difference to the percentages of cells 330 
classed as phenotypically B, T or otherwise. We also evaluated the CD3 staining 331 
properties of B220+ CD19+ cells prior to gating; as shown in Supplementary Fig. S5D, 332 
the B220+CD19+ cells (in red) showed virtually no overlap with the CD3int-hi 333 
population (in blue), supporting the distinction between these populations of cells.  334 
Parenchymal Lung Cell Responses to Chronic PA Infection 335 
Next, we examined the potential of cells within lung tissue to produce IL-17. Lung 336 
homogenates showed a significant increase in total cells expressing IL-17 2 weeks 337 
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following treatment with PA-laden beads in WT mice (Fig 3A and B), distributed 338 
equally between CD3+ and CD3- populations (Fig 3C-E). The CD3+IL-17+ population 339 
was composed mainly of CD4+ (Th17) and γδ T cells in approximately equal 340 
numbers; NK/NK T cells were not detected (Fig 3F-H). The majority of IL-17 341 
expression from the CD3- population is from non-B (B220-) cell sources, consistent 342 
with an innate lymphoid cell population. B cells constituted 3.83% of the CD3- cells 343 
expressing IL-17 (Fig 3I), with virtually no IL-17 production from NK cells (Fig 3J). 344 
The CD3-B220+ population predominantly expressed IL-17 from the CD43+ subset, 345 
consistent with a B1 cell population (Fig. 4A-D). Lung immunostaining confirmed 346 
parenchymal B and T cell responses with PA infected animals demonstrating 347 
peribronchial mononuclear B cell (B220+) and more widely distributed T cells (Thy 348 
1.2+) (Fig. 4E-F). 349 
Response to Pulmonary PA infection in B cell deficient mice 350 
 A small fraction of the IL-17 producing cells in our model of chronic P. 351 
aeruginosa infection were B cells, with characteristics of innate B1 cells. Innate B 352 
cells have been implicated as important in host defence against bacterial infection, 353 
both through their production of natural immunoglobulin that can bind to bacterial 354 
pathogens as well as differentiating into GM-CSF producing protective cells(31, 32). 355 
We addressed the role of B cells by these mechanisms in protection against chronic 356 
PA infection in our murine model. We infected mice that lack cells of the B lineage 357 
(µMT) with PA-laden beads and compared their responses to WT animals.  358 
There was no difference in mortality between WT and µMT mice 2 weeks 359 
following infection (1 in 13 infected µMT versus 1 in 18 of WT animals; p = 1.0, 360 
Fisher’s exact test). The proportion of animals chronically infected 2 weeks after 361 
infection was also not significantly different between the groups (6 of 12 µMT versus 362 
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9 of 17 WT animals; p = 1.0, Fisher’s exact test). Further, pulmonary bacterial burden 363 
in chronically infected animals was not significantly different between the groups 364 
(Fig. 5). There was no difference in IL-17 production from PA stimulated mediastinal 365 
lymph node cells at 14 days after infection between WT and µMT mice (data not 366 
shown).  367 
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Discussion 368 
Here we have shown that IL-17 family cytokines play a crucial role in 369 
preventing chronic infection of the airways with PA in a murine model of infection. 370 
The change from intermittent to chronic infection of the airways with PA is a key 371 
transition point in patients with CF; delay of this stage would likely prolong life 372 
expectancy in patients with CF. Thus, enhancing IL-17 actions at this point in the 373 
clinical course of CF could be a potential therapeutic target.  374 
 IL-17 family members have a potent effect on neutrophil production and 375 
mobilization(15, 33). Although we found small reductions in blood neutrophil counts 376 
before and after infection between WT and IL-17RA knockout animals (data not 377 
shown), there was no difference in BAL neutrophil counts between these groups of 378 
animals following infection. However, pulmonary neutrophil recruitment may still 379 
play a critical role in preventing chronic infection via a very early IL-17-dependent 380 
neutrophil influx. In addition, direct IL-17 activation of neutrophils was recently 381 
shown to be required for optimal fungal killing(34). The protective effect of IL-17 in 382 
the pulmonary PA infection model could also result from the ability of IL-17 to 383 
induce antimicrobial peptides such as defensins and the S100 proteins; indeed, in 384 
ocular infections, human β–defensin 2 plays an important role in host defence against 385 
PA(35). In addition, IL-17 induces pro-inflammatory cytokines such as IL-6 and 386 
TNF-α. The lack of weight loss seen in infected IL-17RA knockout mice may reflect 387 
the lack of such inflammatory cytokine production, since these cytokines are 388 
associated with loss of body mass(36). 389 
 We identified a number of different cellular sources that produce IL-17 in this 390 
model of infection. In the draining mediastinal lymph node, we found a considerable 391 
expansion of cells following infection that were predominantly cells with the 392 
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characteristics of Group 3 ILCs. Specifically, given their production of IL-17, these 393 
are likely to be lymphoid-tissue inducer cells (LTi). Further characterization using the 394 
ILC3 markers CD127 and RORγt will be required to establish the identity of these 395 
cells beyond doubt. ILC3/LTi cells have been implicated in host resistance to 396 
extracellular bacteria, chronic inflammation or tissue repair. Recently, Group 3 ILCs 397 
have been shown to present antigen and to contribute to the control of CD4+ T cell 398 
responses to commensal bacteria(37, 38). The expansion of group 3 ILCs in the 399 
mediastinal lymph nodes has been previously described in a helminth infection 400 
model(39). This study found that in mesenteric lymph nodes, the group 3 ILCs 401 
migrated in a CCR7 dependent fashion from the intestine. The origin of the group 3 402 
ILCs that migrate to mediastinal lymph nodes is not clear, especially as the lung has a 403 
very low number of these cells. The function of these cells in this location is also not 404 
clear. Neutrophils are recruited to regional lymph nodes in infection and 405 
inflammation. In this location, they potentially fulfill a number of roles, including 406 
limiting pathogen escape, modulating subcapsular sinus macrophage numbers, and 407 
influencing dendritic cell maturation and antigen presentation (reviewed in(40)). IL-408 
17 family cytokines released by group 3 ILCs within draining lymph nodes would 409 
thus be one mechanism whereby neutrophils could be recruited to this site during an 410 
infection. Further work will be required to explore these possibilities. 411 
 We found a small but significant population of B cells that produced IL-17 in 412 
the mesenteric lymph nodes following infection. B cell production of IL-17 has been 413 
found in a model of Trypanosoma cruzi infection in mice(41). Our study suggests that 414 
B1 cells are a source of this cytokine. B1 cells are the predominant B cell in pleural 415 
and peritoneal compartments and continuously traffic into these areas by a CXCL13-416 
dependent pathway(42). Following activation, they migrate to regional lymph nodes 417 
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and intestinal lamina propria(26, 43). The accumulation of IL-17-producing B1 cells 418 
in mediastinal lymph nodes following infection reported here may reflect this 419 
activation-induced cell trafficking. Immature plasma cells (plasmablasts) may also 420 
express CCD19, B220 and CD43, and thus may also be the B cells producing IL-17 421 
within the mediastinal lymph nodes described here(44). Further work with genetic 422 
marking of distinct lineages will be required to identify these cells unequivocally. 423 
These mediastinal node cells from PA infected animals require further stimulation 424 
with PA to expand the population of B1a cells and to produce secretion of IL-17. This 425 
migration and subsequent division in response to PA is likely produced via TLR 426 
stimulation with LPS from the Gram-negative organisms, as has been shown 427 
previously(45). However, given that mice lacking B cells showed no defect in the 428 
incidence of chronic infection with PA, these B1 cells are dispensable as a source of 429 
protective IL-17. 430 
Within lung parenchyma following infection, IL-17 was produced from CD4+ 431 
cells with properties of Th17 cells as well as γδ T cells. Both these cell types were 432 
increased in the lung following chronic infection. Generation of PA-specific Th17 433 
cells by a pseudomonal vaccine may thus be of importance in providing protection 434 
against chronic infection. 435 
The PA strains here were both derived from CF patients but showed important 436 
differences in the model (Fig. 1). Apart from the known difference in alginate 437 
production in the NH57388A strain, genome sequencing revealed multiple genetic 438 
differences between this strain and YH5 (Supplementary Fig. S1). The alginate 439 
overproduction in NH57388A is due to a deletion of part of the mucA gene that 440 
encodes a MucA anti-sigma factor (22). Also of interest is that YH5 has lost the 441 
genetic machinery necessary to synthesise pyocyanin. This could account for its 442 
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relative lack of virulence in the IL-17RA knockout animals compared to the 443 
NH57388A strain, but further work will be required to determine which of these 444 
genetic differences are most important. 445 
 Chronic PA infection is not only a significant problem in CF, but also in 446 
COPD(46) and non-CF bronchiectasis(47). Delaying the onset of chronic infection in 447 
such patient groups would represent a very valuable therapeutic goal. Antibiotics can 448 
delay this progression but cannot prevent this transition. A number of vaccines against 449 
PA have been developed to attempt to prevent chronic infection; as of yet, none of 450 
these have shown clinical efficacy(48). The work described here opens a new 451 
perspective on the prevention and treatment of such PA infection. Potential therapies 452 
based on augmenting IL-17 action – through vaccination or otherwise – could be of 453 
great value in delaying or preventing chronic PA infection in chronic lung disease.  454 
   455 
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 30
Figure Legends 620 
Figure 1. Responses of WT and IL-17RA Knockout Animals to Pulmonary PA 621 
Infection. (A) Pulmonary bacterial burden in chronically infected animals at 2 weeks 622 
post infection. Line indicates median. P-value relates to Mann-Whitney test. Pooled 623 
results from two experiments each with 10 per group. (B) Kaplan-Meir survival 624 
curves of WT (circles) or IL-17RA KO animals (squares) infected with the 625 
NH57388A strain (n = 10 per group). Differences significant, log-rank test, p = 626 
0.0092. (C) Weight changes in animals (n=10) remaining chronically infected at 14 627 
days following infection with the YH5 strain showing WT (circles) or IL-17RA KO 628 
animals (squares). Each point is the mean weight at that time; error bars are SEM. 629 
Differences between the groups are significant, p<0.0001 by repeated measures 630 
ANOVA. (D - E) Lung sections stained with H&E from infected WT mice 2 weeks 631 
after infection with YH5 strain. Arrows show agar beads. Scale bar = (E) = 50 µm, 632 
(F) = 10 µm. (F), Large (>50 cells deep) monocytic accumulations in IL-17RA KO 633 
mice. Scale bar is 50 µm. (G), Histological score of indicated animals 2 weeks after 634 
infection with YH5 strain. P-value = 0.7266 via Mann-Whitney test. 635 
Figure 2. Immune responses following PA infection. Two weeks after infection, 636 
mediastinal lymph node cells from WT mice treated as shown were stimulated ex vivo 637 
with heat-killed PA strains (MOI 30) or left unstimulated for 3 days. Levels of IL-638 
17A (A) secretion are shown; bars are means and error bars are SEM. **, 639 
significantly different from sterile beads, p < 0.01, t test. Un, unstimulated. NH, 640 
NH57388A. Representative of results from three separate experiments. (B), Flow 641 
cytometric stimulated (3 day) mediastinal lymph node cells stained as shown. The 642 
CD3lo-int population is outlined in red; the CD3int-hi population is outlined in black. The 643 
total numbers of cells recovered in each gate is shown next to gate. (C) Flow 644 
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cytometry of lymph node cells as in (B) but gated on the CD3int-hi population. (D), as 645 
C but gated on the CD3lo-int population. (E) Flow cytometry of cells as in (B) but 646 
gated as indicated. Percentage of cells in each quadrant is shown. (F) Fold-increase in 647 
PA-binding IgM and IgG produced by mediastinal lymph node cells from infected 648 
animals restimulated with PA strains ex vivo as shown, compared to unstimulated 649 
cells. Columns represent mean for triplicate wells; error bar is SEM. Columns were 650 
compared to a theoretical mean of 1.0 by Student’s t-test. NS, non-significant. *, p 651 
<0.05. **, p <0.01.  652 
Figure 3. Lung parenchymal responses to PA infection. (A), Representative 653 
intracellular expression of IL-17A in lung parenchymal cells 2 weeks following 654 
instillation of sterile or PA-laden (strain NH57388A) beads. Numbers show 655 
percentage of the total cells in ringed area. (B), Percentage of total lung parenchymal 656 
cells expressing IL-17A 2 weeks after introduction of sterile or PA-laden beads. Each 657 
symbol represents an individual animal; line shows median. P-value relates to Mann-658 
Whitney test. (C), Representative expression of intracellular IL-17A in CD3+ and 659 
CD3- populations in lung 2 weeks following PA infection as assessed by flow 660 
cytometry. (D) and (E), as B but showing the percentage of CD3+ and CD3- cells 661 
respectively expressing intracellular IL-17A. (F) – (H), Flow cytometry of CD3+IL-662 
17A+ cells expressing the markers indicated; boxed areas are deemed positive relative 663 
to isotype controls. Figures show percentage of the total CD3+IL-17A+ population 664 
expressing the indicated marker. (I) – (J) as F-H but gated on CD3-IL-17A+ cells. 665 
Figure 4. Characteristics of B cells in lungs of animals instilled with PA-laden 666 
beads. (A-D), Two-weeks following transtracheal instillation of PA-laden agar beads, 667 
the lungs were homogenized, cells polyclonally stimulated, extracellularly stained for 668 
CD3, B220 and CD43, then permeabilized and stained for intracellular IL-17A, 669 
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followed by flow cytometry. (A) and (B), Representative plots of live CD3- 670 
population expression of B220 and IL-17A. Values above gates represent percentage 671 
of total IL-17A+ cells shown in drawn gate. (C) and (D), Representative plots of CD3-672 
B220+ cells expressing IL-17A and CD43. Quadrant values represent percent of total 673 
cells. Representative of two separate experiments. (E-F), Immunostaining of lung 674 
sections from animals 2 weeks following infection with NH57388A, with staining for 675 
B cells (E), B220 staining indicated in red and boxed area shown enlarged to the right, 676 
or T cells (F), Thy1.2 indicated in red and boxed area shown enlarged to the right. 677 
Nuclei are counter stained green. Scale bar is 20 µm. 678 
Figure 5. Bacterial counts in WT and µMT Mice Following Infection. Animals 679 
were infected with the NH57388A strain. Each symbol is an individual animal; line 680 
indicates the median. P value is for Mann Whitney test between the groups. 681 
 682 
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